“…The increasing resistance of pathogenic microorganisms to antibiotics in the world, and recently in Algeria, leading to the resurgence of more complex infections (Baba Ahmed-Kazi Tani and Arlet, 2014), has pushed researchers to discover new bioactive molecules. The capacity of endophytic fungi to biosynthesize bioactive secondary metabolites (more than 20.000 bioactive molecules) (Marson Ascêncio et al, 2014) and their various biological activities such as antimicrobial, anti-viral, anticancer, antioxidant, antidiabetic, and antiinflammatory activity (Sadrati et al, 2013;Bashyal et al, 2014;Shah et al, 2015;Jouda et al, 2016a;Pan et al, 2016;Singh and Kaur 2016;Yao et al, 2017) have made this fungus to be important, as an important source of new bioactive secondary metabolites potentially useful for human medicine and other domains.…”